Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease
CONCLUSION: Among patients with rheumatic diseases, following their first COVID-19 infection, using an EHR-based definition, we found a decreased risk of PASC over calendar time. Aside from glucocorticoids, no specific immunomodulatory medications were associated with increased risk, and risk factors were otherwise similar to those seen in the general population.PMID:38428964 | DOI:10.3899/jrheum.2023-1092 (Source: J Rheumatol)
Source: J Rheumatol - March 1, 2024 Category: Rheumatology Authors: Naomi J Patel Xiaosong Wang Miao Lin Emily N Kowalski Claire E Cook Kathleen M M Vanni Krishan Guzzo Grace Qian Katarina J Bade Alene Saavedra Rathnam Venkat Shruthi Srivatsan Zachary K Williams Jennifer S Hanberg Yumeko Kawano Abigail E Schiff Jeffrey A Source Type: research
Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease
CONCLUSION: Among patients with rheumatic diseases, following their first COVID-19 infection, using an EHR-based definition, we found a decreased risk of PASC over calendar time. Aside from glucocorticoids, no specific immunomodulatory medications were associated with increased risk, and risk factors were otherwise similar to those seen in the general population.PMID:38428964 | DOI:10.3899/jrheum.2023-1092 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - March 1, 2024 Category: Rheumatology Authors: Naomi J Patel Xiaosong Wang Miao Lin Emily N Kowalski Claire E Cook Kathleen M M Vanni Krishan Guzzo Grace Qian Katarina J Bade Alene Saavedra Rathnam Venkat Shruthi Srivatsan Zachary K Williams Jennifer S Hanberg Yumeko Kawano Abigail E Schiff Jeffrey A Source Type: research
Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease
CONCLUSION: Among patients with rheumatic diseases, following their first COVID-19 infection, using an EHR-based definition, we found a decreased risk of PASC over calendar time. Aside from glucocorticoids, no specific immunomodulatory medications were associated with increased risk, and risk factors were otherwise similar to those seen in the general population.PMID:38428964 | DOI:10.3899/jrheum.2023-1092 (Source: J Rheumatol)
Source: J Rheumatol - March 1, 2024 Category: Rheumatology Authors: Naomi J Patel Xiaosong Wang Miao Lin Emily N Kowalski Claire E Cook Kathleen M M Vanni Krishan Guzzo Grace Qian Katarina J Bade Alene Saavedra Rathnam Venkat Shruthi Srivatsan Zachary K Williams Jennifer S Hanberg Yumeko Kawano Abigail E Schiff Jeffrey A Source Type: research
Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease
CONCLUSION: Among patients with rheumatic diseases, following their first COVID-19 infection, using an EHR-based definition, we found a decreased risk of PASC over calendar time. Aside from glucocorticoids, no specific immunomodulatory medications were associated with increased risk, and risk factors were otherwise similar to those seen in the general population.PMID:38428964 | DOI:10.3899/jrheum.2023-1092 (Source: Journal of Rheumatology)
Source: Journal of Rheumatology - March 1, 2024 Category: Rheumatology Authors: Naomi J Patel Xiaosong Wang Miao Lin Emily N Kowalski Claire E Cook Kathleen M M Vanni Krishan Guzzo Grace Qian Katarina J Bade Alene Saavedra Rathnam Venkat Shruthi Srivatsan Zachary K Williams Jennifer S Hanberg Yumeko Kawano Abigail E Schiff Jeffrey A Source Type: research
Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease
CONCLUSION: Among patients with rheumatic diseases, following their first COVID-19 infection, using an EHR-based definition, we found a decreased risk of PASC over calendar time. Aside from glucocorticoids, no specific immunomodulatory medications were associated with increased risk, and risk factors were otherwise similar to those seen in the general population.PMID:38428964 | DOI:10.3899/jrheum.2023-1092 (Source: J Rheumatol)
Source: J Rheumatol - March 1, 2024 Category: Rheumatology Authors: Naomi J Patel Xiaosong Wang Miao Lin Emily N Kowalski Claire E Cook Kathleen M M Vanni Krishan Guzzo Grace Qian Katarina J Bade Alene Saavedra Rathnam Venkat Shruthi Srivatsan Zachary K Williams Jennifer S Hanberg Yumeko Kawano Abigail E Schiff Jeffrey A Source Type: research
